Hologic, Inc. (NASDAQ:HOLX) Insider Sells $260,145.02 in Stock

Hologic, Inc. (NASDAQ:HOLX) insider Sean S. Daugherty sold 4,001 shares of the firm’s stock in a transaction that occurred on Monday, May 10th. The shares were sold at an average price of $65.02, for a total transaction of $260,145.02. Following the completion of the transaction, the insider now owns 26,613 shares of the company’s stock, valued at approximately $1,730,377.26. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Shares of NASDAQ HOLX traded down $1.52 during mid-day trading on Wednesday, reaching $62.95. 2,740,221 shares of the company’s stock were exchanged, compared to its average volume of 2,163,184. Hologic, Inc. has a 52 week low of $49.19 and a 52 week high of $85.00. The firm has a 50-day moving average price of $72.08 and a two-hundred day moving average price of $73.68. The firm has a market capitalization of $16.13 billion, a price-to-earnings ratio of 15.07, a price-to-earnings-growth ratio of 0.62 and a beta of 1.27. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.79 and a quick ratio of 1.47.

Hologic (NASDAQ:HOLX) last announced its quarterly earnings data on Wednesday, April 28th. The medical equipment provider reported $2.59 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.62 by ($0.03). Hologic had a net margin of 29.53% and a return on equity of 45.24%. The firm had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same quarter in the prior year, the firm posted $0.57 earnings per share. The company’s revenue was up 103.4% on a year-over-year basis. As a group, sell-side analysts forecast that Hologic, Inc. will post 7.17 EPS for the current fiscal year.

A number of hedge funds have recently bought and sold shares of the business. Louisiana State Employees Retirement System grew its holdings in shares of Hologic by 21.2% during the fourth quarter. Louisiana State Employees Retirement System now owns 16,000 shares of the medical equipment provider’s stock worth $1,165,000 after purchasing an additional 2,800 shares in the last quarter. NuWave Investment Management LLC grew its stake in Hologic by 6,594.1% in the fourth quarter. NuWave Investment Management LLC now owns 1,138 shares of the medical equipment provider’s stock worth $83,000 after purchasing an additional 1,121 shares during the period. CFO4Life Group LLC purchased a new stake in Hologic in the fourth quarter worth $384,000. Sowell Financial Services LLC grew its stake in Hologic by 5.0% in the fourth quarter. Sowell Financial Services LLC now owns 18,478 shares of the medical equipment provider’s stock worth $1,346,000 after purchasing an additional 875 shares during the period. Finally, McGuire Investment Group LLC grew its stake in Hologic by 19.8% in the fourth quarter. McGuire Investment Group LLC now owns 98,359 shares of the medical equipment provider’s stock worth $7,163,000 after purchasing an additional 16,228 shares during the period. 92.43% of the stock is owned by institutional investors and hedge funds.

A number of brokerages recently issued reports on HOLX. Wells Fargo & Company raised their price objective on shares of Hologic from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, January 28th. Jefferies Financial Group raised their price target on shares of Hologic from $106.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 5th. BTIG Research raised their price target on shares of Hologic from $84.00 to $91.00 and gave the stock a “buy” rating in a report on Monday, February 22nd. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell lowered their price target on shares of Hologic from $90.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, May 5th. Finally, Robert W. Baird raised their price target on shares of Hologic from $84.00 to $91.00 and gave the stock a “buy” rating in a report on Monday, March 1st. One analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $85.44.

About Hologic

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.

Featured Article: What does RSI mean?

Insider Buying and Selling by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.